Legalization doesn’t improve youth hashish use, fed research finds (Publication: November 25, 2022)

ID 2024 medical marijuana push; Feds define psychedelic analysis priorities; SD looking licenses for medical hashish sufferers

Subscribe to obtain Marijuana Second’s e-newsletter in your inbox each weekday morning. It’s one of the best ways to ensure you know which hashish tales are shaping the day.


Your help makes Marijuana Second doable…

Free to learn (however not free to provide)! We’re pleased with our e-newsletter and the reporting we publish at Marijuana Second, and we’re joyful to offer it at no cost. However it takes numerous work and assets to make this occur.

For those who worth Marijuana Second, put money into our success on Patreon so we are able to broaden our protection and extra readers can profit: https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Idaho activists launched a signature drive to position a medical hashish legalization initiative on the state’s 2024 poll.

The Nationwide Institute of Psychological Well being filed a discover laying out its priorities for psychedelic analysis—together with limitations for animal-based analysis and guidelines for trials involving kids.

A new federally funded research discovered that legalizing marijuana “was not considerably associated” to “the likelihood or frequency of self-reported past-year hashish use” by adolescents and that “youth who spent extra of their adolescence below legalization had been no kind of prone to have used hashish at age 15 years than adolescents who spent little or no time below legalization.”

  • “Findings aren’t per modifications within the prevalence or frequency of adolescent hashish use after legalization.”

A South Dakota Sport, Fish & Parks Division official mentioned medical hashish sufferers received’t be denied state looking licenses regardless of the federal prohibition on gun purchases by individuals who use marijuana.

/ FEDERAL

The Nuclear Regulatory Fee is amending its drug testing necessities.

/ STATES

A New Hampshire consultant turned the brand new advisory board chair for the New Hampshire Hashish Affiliation.

The Michigan Court docket of Appeals upheld a decide’s dismissal of a lawsuit a marijuana enterprise filed towards Easton Township over the denial of a license.

Rhode Island’s high marijuana regulator spoke concerning the impending launch of authorized leisure gross sales.

Missouri regulators outlined the method for medical hashish companies to transform to complete licenses to serve the leisure market.

Hawaii’s Twin Use of Hashish Process Pressure will meet on Monday.

The Oregon Process Pressure on Hashish-Derived Intoxicants and Unlawful Hashish Manufacturing will meet on Monday.


Marijuana Second is monitoring greater than 1,500 hashish, psychedelics and drug coverage payments in state legislatures and Congress this 12 months. Patreon supporters pledging a minimum of $25/month get entry to our interactive maps, charts and listening to calendar in order that they don’t miss any developments.

Be taught extra about our marijuana invoice tracker and change into a supporter on Patreon to get entry.

/ LOCAL

Cell, Alabama’s Metropolis Council debated whether or not medical hashish companies ought to be allowed.

Stearns County, Minnesota’s legal professional expressed opposition to marijuana legalization, saying she doesn’t “see something good popping out of creating extra individuals potheads.”

/ INTERNATIONAL

Canadian federal officers appointed members to an professional panel charged with reviewing the nation’s marijuana legislation.

Romanian lawmakers hosted a debate on medical hashish legalization.

A European Monitoring Centre for Medication and Drug Dependancy official gave a chat on “rising modifications in Europe’s hashish scenario.”

Members of the UK House Affairs Committee visited Scotland as a part of an inquiry into drug coverage.

Thailand’s Division of Medical Companies printed medical hashish tips.

/ SCIENCE & HEALTH

A assessment demonstrated “the neuroprotective impact of cannabidiol, highlighting its basic mechanism of motion and disease-specific pathways in Parkinson’s illness (PD) and Alzheimer’s illness (AD).”

A research discovered that “melancholy is a danger issue for cannabis-related [emergency department] visits” however that “hashish legalisation didn’t additional elevate the chance amongst people recognized with melancholy.”

/ BUSINESS

Ascend Wellness Holdings, Inc introduced modifications to its board of administrators.

Ensure to subscribe to get Marijuana Second’s every day dispatch in your inbox.


The put up Legalization doesn’t improve youth hashish use, fed research finds (Publication: November 25, 2022) appeared first on Marijuana Second.

You May Also Like